Liu Yen-Chin, Wu Sheng-Nan
Department of Anaesthesiology, National Cheng-Kung University Medical College, Tainan, Taiwan.
Clin Exp Pharmacol Physiol. 2005 Dec;32(12):1078-87. doi: 10.1111/j.1440-1681.2005.04315.x.
The effects of BAY 41-2272, a nitric oxide-independent activator of soluble guanylyl cyclase, on Ca2+ signalling and ion currents were investigated in pituitary GH3 cells. Intracellular Ca2+ concentrations ([Ca2+]i) in these cells were increased by BAY 41-2272. Removing extracellular Ca2+ abolished the BAY 41-2272-induced increase in [Ca2+]i. After [Ca2+]i was elevated by BAY 41-2272 (300 nmol/L), subsequent application of 1-benzyl-3-(5'-hydroxymethyl-2'-furyl) indazole (YC-1; 1 micromol/L) did not increase [Ca2+]i further. In whole-cell recordings, BAY 41-2272 reversibly stimulated Ca2+-activated K+ current (I(K(Ca))) with an EC50 of 225 +/- 8 nmol/L. At 3 micromol/L, BAY 41-2272 slightly and significantly decreased L-type Ca2+ current. In the cell-attached configuration, BAY 41-2272 (300 nmol/L) enhanced the activity of large-conductance Ca2+-activated K+ (BK(Ca)) channels. After BK(Ca) channel activity was stimulated by spermine NONOate (30 micromol/L) or YC-1 (10 micromol/L) in cell-attached patches, subsequent application of BAY 41-2272 (300 nmol/L) further increased the channel open probability. In the inside-out configuration, BAY 41-2272 applied to the intracellular surface of excised patches enhanced BK(Ca) channel activity. Unlike 1 micromol/L paxilline, 1H-[1,2,4]oxadiazolol-[4,3a] quinoxalin-1-one (ODQ; 10 micromol/L) or heme (10 micromol/L) had no effect on BAY 41-2272-stimulated channel activity. BAY 41-2272 caused no shift in the activation curve of BK(Ca) channels; however, it did increase the Ca2+ sensitivity of these channels. At 300 nmol/L, BAY 41-2272 reduced the firing rate of spontaneous action potentials stimulated by thyrotropin-releasing hormone (10 micromol/L). The BK(Ca) channel activity was also enhanced by 300 nmol/L BAY 41-2272 in neuroblastoma IMR-32 cells. Therefore, the BAY 41-2272-induced increase in [Ca2+]i is primarily explained by an increase in Ca2+ influx. The BAY 41-2272-mediated simulation of IK(Ca) may result from direct activation of BKCa channels and indirectly as a result of elevated [Ca2+]i.
在垂体GH3细胞中研究了可溶性鸟苷酸环化酶的一氧化氮非依赖性激活剂BAY 41-2272对Ca2+信号传导和离子电流的影响。BAY 41-2272可增加这些细胞内的Ca2+浓度([Ca2+]i)。去除细胞外Ca2+可消除BAY 41-2272诱导的[Ca2+]i升高。在BAY 41-2272(300 nmol/L)使[Ca2+]i升高后,随后应用1-苄基-3-(5'-羟甲基-2'-呋喃基)吲唑(YC-1;1 μmol/L)不会使[Ca2+]i进一步升高。在全细胞记录中,BAY 41-2272以225±8 nmol/L的半数有效浓度(EC50)可逆性刺激Ca2+激活的K+电流(I(K(Ca)))。在3 μmol/L时,BAY 41-2272轻微但显著降低L型Ca2+电流。在细胞贴附模式下,BAY 41-2272(300 nmol/L)增强了大电导Ca2+激活的K+(BK(Ca))通道的活性。在用精胺硝普钠(30 μmol/L)或YC-1(10 μmol/L)刺激细胞贴附膜片上的BK(Ca)通道活性后,随后应用BAY 41-2272(300 nmol/L)可进一步增加通道开放概率。在膜内面向外模式下,将BAY 41-2272应用于切除膜片的细胞内表面可增强BK(Ca)通道活性。与1 μmol/L的帕西丁不同,1H-[1,2,4]恶二唑并[4,3a]喹喔啉-1-酮(ODQ;10 μmol/L)或血红素(10 μmol/L)对BAY 41-2272刺激的通道活性无影响。BAY 41-2272不会使BK(Ca)通道的激活曲线发生偏移;然而,它确实增加了这些通道对Ca2+的敏感性。在300 nmol/L时,BAY 41-2272降低了促甲状腺激素释放激素(10 μmol/L)刺激的自发性动作电位的发放频率。在神经母细胞瘤IMR-32细胞中,300 nmol/L 的BAY 41-2272也增强了BK(Ca)通道活性。因此,BAY 41-2272诱导的[Ca2+]i升高主要是由于Ca2+内流增加所致。BAY 41-2272介导的IK(Ca)模拟可能是由于直接激活BKCa通道以及间接由于[Ca2+]i升高所致。